Palogic Value Management »

Actuate Therapeutics shares owned by Palogic Value Management

Quarter-by-quarter ownership of Actuate Therapeutics (ACTU) shares owned by Palogic Value Management from 13F filings

Historical chart of Palogic Value Management investment in Actuate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Actuate Therapeutics held by Palogic Value Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Actuate Therapeutics by Palogic Value Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $274k 100k 2.74

More positions owned by Palogic Value Management

Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Exxon Mobil Corporation (XOM)
Ssga Active Etf Tr State Street Bla (SRLN)
Bhp Billiton Sponsored Ads (BHP)
Microsoft Corporation (MSFT)
Open Lending Corp (LPRO)
Spdr Series Trust State Street Spd (BIL)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Nuveen Insured Tax-Free Adv Munici (NEA)
Abbvie (ABBV)
Shell Spon Ads (SHEL)
Amazon (AMZN)
Health Catalyst (HCAT)

View all positions for Palogic Value Management

Top funds holding Actuate Therapeutics

BIOS Capital Management
Voss Capital
Vanguard Group
BlackRock
Vanguard Capital Management
Geode Capital Management
Connective Capital Management
Palogic Value Management
Northern Trust
Texas Capital Bank Wealth Management Services
State Street Corporation
Vanguard Fiduciary Trust
Vanguard Portfolio Management
ABS Direct Equity Fund
Rock Creek Group

View all funds holding Actuate Therapeutics